Gufic Biosciences Limited (BOM: 509079)
India
· Delayed Price · Currency is INR 446.65
0.00 (0.00%)
At close: Nov 14, 2024
Gufic Biosciences Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Nov '24 Nov 13, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Market Capitalization | 44,789 | 28,394 | 18,095 | 24,129 | 8,896 | 3,670 | Upgrade
|
| Market Cap Growth | 53.07% | 56.92% | -25.01% | 171.24% | 142.42% | -38.00% | Upgrade
|
| Enterprise Value | 47,554 | 31,818 | 19,487 | 23,753 | 10,059 | 4,721 | Upgrade
|
| Last Close Price | 446.65 | 283.08 | 186.54 | 248.63 | 114.12 | 47.05 | Upgrade
|
| PE Ratio | 52.70 | 32.39 | 22.69 | 25.15 | 25.03 | 16.14 | Upgrade
|
| PS Ratio | 5.57 | 3.52 | 2.62 | 3.10 | 1.82 | 0.97 | Upgrade
|
| PB Ratio | 7.80 | 5.33 | 5.20 | 8.97 | 5.13 | 2.84 | Upgrade
|
| P/TBV Ratio | 6.59 | 5.39 | 5.21 | 8.99 | 5.14 | 2.85 | Upgrade
|
| P/FCF Ratio | - | - | - | 128.44 | 11.88 | 50.60 | Upgrade
|
| P/OCF Ratio | - | - | - | 22.71 | 10.20 | 7.79 | Upgrade
|
| EV/Sales Ratio | 5.92 | 3.94 | 2.82 | 3.05 | 2.06 | 1.25 | Upgrade
|
| EV/EBITDA Ratio | 33.97 | 22.60 | 14.91 | 16.61 | 12.51 | 9.56 | Upgrade
|
| EV/EBIT Ratio | 36.50 | 24.26 | 16.90 | 18.40 | 14.87 | 12.25 | Upgrade
|
| EV/FCF Ratio | -193.06 | - | - | 126.44 | 13.44 | 65.10 | Upgrade
|
| Debt / Equity Ratio | 0.63 | 0.63 | 0.96 | 0.24 | 0.35 | 0.98 | Upgrade
|
| Debt / EBITDA Ratio | 2.27 | 2.25 | 2.43 | 0.44 | 0.73 | 2.41 | Upgrade
|
| Debt / FCF Ratio | - | - | - | 3.43 | 0.82 | 17.43 | Upgrade
|
| Asset Turnover | - | 0.83 | 1.00 | 1.71 | 1.22 | 1.10 | Upgrade
|
| Inventory Turnover | - | 2.08 | 2.27 | 4.01 | 2.37 | 1.71 | Upgrade
|
| Quick Ratio | - | 0.89 | 0.81 | 0.88 | 0.80 | 0.46 | Upgrade
|
| Current Ratio | - | 1.61 | 1.61 | 1.72 | 1.59 | 1.14 | Upgrade
|
| Return on Equity (ROE) | - | 19.57% | 25.84% | 43.31% | 29.22% | 22.17% | Upgrade
|
| Return on Assets (ROA) | - | 8.39% | 10.43% | 17.67% | 10.58% | 7.01% | Upgrade
|
| Return on Capital (ROIC) | 10.43% | 10.59% | 14.20% | 28.39% | 17.23% | 11.23% | Upgrade
|
| Earnings Yield | 1.90% | 3.03% | 4.40% | 3.97% | 4.97% | 6.18% | Upgrade
|
| FCF Yield | -0.55% | -4.23% | -11.84% | 0.78% | 8.41% | 1.98% | Upgrade
|
| Dividend Yield | 0.02% | 0.04% | 0.05% | 0.04% | 0.09% | 0.11% | Upgrade
|
| Payout Ratio | 2.33% | 1.13% | 1.31% | 0.96% | 0.82% | 2.15% | Upgrade
|
| Buyback Yield / Dilution | -2.60% | -1.63% | - | - | -24.56% | - | Upgrade
|
| Total Shareholder Return | -2.58% | -1.59% | 0.05% | 0.04% | -24.47% | 0.11% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.